Shah Nihar, Shaaban Hamid, Spira Robert, Slim Jihad, Boghossian Jack
Department of Gastroenterology, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA.
J Glob Infect Dis. 2014 Apr;6(2):82-5. doi: 10.4103/0974-777X.132053.
Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.
静脉注射免疫球蛋白（IVIG）已被用于治疗复发性和难治性艰难梭菌结肠炎患者。它越来越多地用于初发临床表现为重症结肠炎的患者。在此，我们报告一例通过IVIG成功治疗的重症艰难梭菌结肠炎病例，并回顾医学文献以确定该治疗策略的最佳时机和临床特征。
